Bronte Capital Management’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-19,306
Closed -$4.31M 29
2023
Q2
$4.31M Buy
19,306
+157
+0.8% +$32.1K 0.42% 27
2023
Q1
$4.23M Sell
19,149
-21,840
-53% -$5.38M 0.49% 24
2022
Q4
$8.89M Sell
40,989
-905
-2% -$241K 1.12% 19
2022
Q3
$11.1M Sell
41,894
-12,916
-24% -$3.28M 1.38% 18
2022
Q2
$11.5M Buy
+54,810
New +$12.2M 1.31% 23

Other funds holding ALB

Bronte Capital Management's ALB Position: Q3 2023 in Review

Bronte Capital Management sold out of Albemarle (ALB) in Q3 2023, closing a stake of 19,306 shares — an estimated $4.31M sold.

Bronte Capital Management first reported a position in ALB in Q2 2022 and held it in 5 quarters. The position peaked at $11.5M in Q2 2022. 1,003 funds tracked by Wall St. Rank hold ALB as of Q3 2023.

  • Bronte Capital Management reported no remaining Albemarle position as of Q3 2023 after selling out during the quarter.
  • Bronte Capital Management sold 19,306 Albemarle shares in Q3 2023, an estimated $4.31M.
  • Bronte Capital Management first reported a position in Albemarle in Q2 2022 and held it in 5 quarters.
  • Bronte Capital Management's Albemarle position peaked at $11.5M in Q2 2022.
  • 1,003 funds tracked by Wall St. Rank held Albemarle as of Q3 2023.

Based on Bronte Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.